# A rare case of a giant pulmonary solitary fibrous tumor: Diagnostic and therapeutic challenges in the absence of malignancy

**Authors:** Nouman Aziz, Waseem Nabi, Sukhrob Makhkamov, Yasmine Elsherif, Adnan Bhat, Sonu Sahni

PMC · DOI: 10.1016/j.rmcr.2025.102191 · Respiratory Medicine Case Reports · 2025-03-14

## TL;DR

A rare case of a large lung tumor shows that even big tumors can be non-cancerous, highlighting the need for careful diagnosis and surgery.

## Contribution

Presents a rare case of a giant pulmonary SFT with non-malignant features, emphasizing diagnostic and therapeutic challenges.

## Key findings

- A 14 x 12 x 23 cm pulmonary SFT was diagnosed in a 60-year-old woman with no signs of malignancy.
- Successful surgical resection was achieved despite the tumor's size and compressive effects.
- The case highlights the importance of histopathology and imaging in managing large SFTs.

## Abstract

Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms predominantly arising from the pleura but occasionally occurring in extrapleural locations. Pulmonary parenchymal SFTs of extreme size are exceedingly uncommon and present diagnostic and therapeutic challenges.

We report the case of a 60-year-old female with a 14 x 12 × 23 cm pulmonary SFT presenting with a two-week history of productive cough and significant weight loss. Imaging revealed a massive heterogeneous mass in the left lower lobe, compressing lung parenchyma, causing pleural effusion and atelectasis, and raising concerns for metastatic spread to the liver and spleen. Histological examination confirmed the diagnosis of SFT, with spindle-cell morphology and positive immunohistochemical staining for CD34 and STAT6. Despite the tumor's size and compressive effects, histopathology showed no necrosis, pleomorphism, or high mitotic activity, indicative of a non-aggressive phenotype. The patient underwent successful surgical resection via thoracotomy and is under long-term follow-up.

This case highlights the unique diagnostic complexity of SFTs, particularly with tumors of exceptional size. While larger SFTs often suggest malignant potential, the absence of typical markers of malignancy in this case emphasizes the unpredictable behavior of these tumors. Imaging and immunohistochemical evaluation are critical for diagnosis, and surgical resection remains the cornerstone of management.

This rare case underscores the importance of thorough diagnostic evaluation and surgical management in addressing giant pulmonary SFTs. Despite their potential for malignant transformation, careful histopathological analysis and multidisciplinary collaboration can guide optimal treatment and long-term surveillance for these unpredictable tumors.

## Linked entities

- **Proteins:** CD34 (CD34 molecule), STAT6 (signal transducer and activator of transcription 6)

## Full-text entities

- **Genes:** STAT6 (signal transducer and activator of transcription 6) [NCBI Gene 6778] {aka D12S1644, HIES6, IL-4-STAT, STAT6B, STAT6C}, CD34 (CD34 molecule) [NCBI Gene 947]
- **Diseases:** SFTs (MESH:D054364), atelectasis (MESH:D001261), weight loss (MESH:D015431), pleural effusion (MESH:D010996), cough (MESH:D003371), malignancy (MESH:D009369), necrosis (MESH:D009336)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12264229/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12264229/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC12264229/full.md

---
Source: https://tomesphere.com/paper/PMC12264229